- Home
- MTEM vs FOXO Comparison
MTEM vs FOXO Comparison
Compare MTEM & FOXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEM
- FOXO
- Stock Information
- Founded
- MTEM 2001
- FOXO 2019
- Country
- MTEM United States
- FOXO United States
- Employees
- MTEM N/A
- FOXO N/A
- Industry
- MTEM Biotechnology: Biological Products (No Diagnostic Substances)
- FOXO Retail: Computer Software & Peripheral Equipment
- Sector
- MTEM Health Care
- FOXO Technology
- Exchange
- MTEM Nasdaq
- FOXO Nasdaq
- Market Cap
- MTEM 9.7M
- FOXO 8.0M
- IPO Year
- MTEM N/A
- FOXO N/A
- Fundamental
- Price
- MTEM $0.35
- FOXO $0.32
- Analyst Decision
- MTEM
- FOXO
- Analyst Count
- MTEM 0
- FOXO 0
- Target Price
- MTEM N/A
- FOXO N/A
- AVG Volume (30 Days)
- MTEM 15.2M
- FOXO 9.1M
- Earning Date
- MTEM 12-27-2024
- FOXO 11-19-2024
- Dividend Yield
- MTEM N/A
- FOXO N/A
- EPS Growth
- MTEM N/A
- FOXO N/A
- EPS
- MTEM N/A
- FOXO N/A
- Revenue
- MTEM $25,470,000.00
- FOXO $1,341,000.00
- Revenue This Year
- MTEM N/A
- FOXO N/A
- Revenue Next Year
- MTEM N/A
- FOXO N/A
- P/E Ratio
- MTEM N/A
- FOXO N/A
- Revenue Growth
- MTEM N/A
- FOXO 196.03
- 52 Week Low
- MTEM $0.30
- FOXO $0.13
- 52 Week High
- MTEM $4.12
- FOXO $1.30
- Technical
- Relative Strength Index (RSI)
- MTEM 41.77
- FOXO 39.05
- Support Level
- MTEM $0.34
- FOXO $0.43
- Resistance Level
- MTEM $0.78
- FOXO $0.53
- Average True Range (ATR)
- MTEM 0.07
- FOXO 0.06
- MACD
- MTEM 0.01
- FOXO -0.03
- Stochastic Oscillator
- MTEM 5.00
- FOXO 7.76
About MTEM Molecular Templates Inc.
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.
About FOXO FOXO Technologies Inc.
FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.